Clinical Trials Directory

Trials / Unknown

UnknownNCT05335746

Ocular Changes in Vitiligo Patients on Therapy

Chorioretinal Changes in Vitiligo Patients on Therapy

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Benha University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers

Summary

Vitiligo patients on systemic and local therapy may have some ocular adverse effects associated with the disease and its therapy.

Detailed description

Chorioretinal changes associated with vitiligo therapy could address patients visual acuity and life style. Early detection of these changes can help these patients to evade such adverse effects.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTOptical coherence tomography angiography (OCT-A)Optical coherence tomography angiography scanning will be done for all subjects in the study.

Timeline

Start date
2022-03-10
Primary completion
2022-09-30
Completion
2022-09-30
First posted
2022-04-19
Last updated
2022-04-19

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05335746. Inclusion in this directory is not an endorsement.